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Abstract Gene-encoded peptide antibiotics are widespread in 
insects, plants and vertebrates and confer protection against 
bacterial and fungal infections. NF-κΒ is an important 
transcription factor for many immunity-related mammalian 
proteins and also for insect immune genes. The activity of NF-
KB is regulated by the interaction with an inhibitor, ΙκΒ. It was 
recently demonstrated that glucocorticoids induce the synthesis 
of IKB in human cell lines. So far, all genes for peptide antibiotics 
have promoter motifs with NF-κΒ binding sites, but its actual 
function in peptide regulation has been studied only in insects. 
Here we show that glucocorticoid treatment of the frog Rana 
esculenta inhibits the transcription of all genes encoding 
antibacterial peptides by inducing the synthesis of ΙκΒα. These 
results suggest that also in vertebrates peptide-mediated innate 
immunity is controlled by NF-KB-regulated transcription. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Gene-encoded peptide antibiotics are widespread in nature 
[1-3]. These molecules confer protection against microorgan-
ism infections in the absence of a clonally based immune 
system. However, both in insects and in vertebrates innate 
immunity provided by antimicrobial peptides may act as a 
first line of defence against infections. 
It is well known that glucocorticoids (GCs) suppress im-
munity in mammals, but the precise mechanism was only 
recently clarified by studies on cultured mammalian cells 
[4,5]. An important transcription factor, NF-κΒ, a homo- or 
heterodimeric, Rel-containing protein, is present in the cyto-
plasm. The activity of NF-κΒ is regulated by preventing it 
from entering into the nucleus when tightly complexed with 
one member of a family of proteins with ankyrin repeats, 
termed IKB. The recent finding that GCs induce the constitu-
tive synthesis of IKBOC [4,5] explains the immunosuppression 
exerted by GCs in mammalian cell cultures. Since several 
genes for antibacterial peptides in mammals have promoter 
motifs that could bind NF-KB-like factors [6-8], we decided 
to investigate whether GC treatment of live frogs could influ-
ence the synthesis of immunity-related peptides in the skin. 
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We selected wild Rana esculenta for the present work, since 
the different antimicrobial peptides in the skin secretion of 
this frog are well known, and the cDNAs encoding their pre-
cursors have been described [9]. The most potent antibacterial 
peptide is esculentin, a 46-residue peptide with two cysteines 
close to the C-terminus, which form an intramolecular disul-
fide bridge [9]. Related molecules, such as brevinins [10], ra-
nalexin [11] and gaegurins/rugosins [12,13], are present in the 
skin secretion of other Rana species. 
2. Materials and methods 
2.1. Frogs and collection of skin secretion 
Specimens of R. esculenta (adults of 20-30 g each) were collected in 
the wild near Rome. They were maintained in individual cages and fed 
larvae of Tenebrie molitor. Skin secretion was collected after giving 
the frog a mild electrical stimulation, usually 10 V for 5 s at three 
equal intervals [14]. The secretion was washed off with 0.05% acetic 
acid and freeze-dried. Typically, a single stimulation of a frog pro-
duced 10-20 mg of freeze-dried crude secretion. 
2.2. HPLC fractionation of frog skin secretion 
About 2 mg of secretion was fractionated by HPLC on a Beckman 
System Gold chromatographer using a C8 reverse-phase column 
(Aquapore RP-300, 4.6x250 mm, Applied Biosystems) eluted with 
a 30-min gradient of 5-60% acetonitrile/2-propanol 4/1 in 0.2% (v/v) 
trifluoroacetic acid, at a flow rate of 0.8 ml/min. Elution of the pep-
tides was monitored using a diode array Beckman model 168 detector. 
2.3. Bacterial counts 
Bacteria were collected from the mouth of frogs by introducing 20 
μΐ LB medium and subsequently withdrawing 5 ul. Bacteria present in 
these samples of 'saliva' were spread in 3 ml soft agar on LB plates. 
Colonies were counted after overnight incubation at 30°C and the 
numbers of viable bacteria are given as colony forming units, cfu/5 
μΐ of saliva. 
2.4. Glucocorticoid treatment of frogs 
Test frogs were first given an electrical stimulation in order to dis-
charge the peptides stored in their skin glands and then carefully 
washed as described above. About 30 min later, a cream (0.25 g/g 
body weight) with a systemically acting glucocorticoid (Clobesol, 
Glaxo, containing 0.05 g clobetasol propionate/100 g) was applied 
to the whole skin surface of the frogs. Alternatively, frogs were in-
jected, every second day for a week, either intraperitoneally or sub-
cutaneously, with 75 μg/g body weight of a water-soluble, locally 
acting, GC derivative (Solu-Medrol, Upjohn), a sodium succinate es-
ter of methylprednisolone. 
2.5. Northern blot analysis 
Total skin RNA was isolated from 5 g of tissue by acidic guanidi-
nium thiocyanate-phenol-chloroform extraction [15]. RNA samples 
(10 μg) were fractionated by electrophoresis in 1.2% agarose gel con-
taining 0.8 M formaldehyde [16] and then blotted directly onto a 
nylon membrane (Sartorius). A cDNA coding for the esculentin pre-
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cursor (clone Escl-17-1, [9]), labeled by random priming, was used as 
probe. 
2.6. Preparation of frog skin crude cytosol 
Frog skins (5 g) were minced with scissors and homogenized with 
Ultra-Turrax in 25 ml ice-cold 20 mM HEPES, containing 2 mM 
EDTA and 1 mM PMSF. The lysates were centrifuged at 4500 rpm 
for 10 min a 4°C. The soluble fractions were further centrifuged at 
12000 rpm for 30 min at 4°C. The supernatants were concentrated 
with a Centricon 30 membrane (Amicon) to 5 ml. Protein concentra-
tions of each preparation were measured using a Bio-Rad protein 
assay kit. 
2.7. Immunoblotting 
Total proteins (100 μg) were separated by 12% SDS polyacrylamide 
gels (Bio-Rad), electroblotted on nitrocellulose (Sartorius) and then 
blocked in TBST (50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 0.1% 
Tween 20) containing 0.5% BSA. The membranes were incubated for 
16 h at 4°C with 1:1000 dilution of polyclonal rabbit antibodies 
against a synthetic peptide corresponding to residues 26-39 from 
the N-terminus of human ΙκΒα (New England Biolabs Inc., Beverly, 
MA, USA). The blots were washed and incubated with 1:2000 dilu-
tion of anti-rabbit Ig-peroxidase conjugate in TBST. After several 
washes, antibody-reactive bands were visualized by enhanced chemi-
luminescence (New England Biolabs Inc.). 
3. Results 
The influence of glucocorticoids on the production of anti-
microbial peptides by skin glands of R esculenta was first 
demonstrated by the effects on the number of aerobic bacteria 
present in the frog mouth. Frogs, kept in cages for 2 weeks 
after capture, normally carried 70-140 cfu/5 μΐ LB saliva. 
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Fig. 1. Reversed-phase HPLC fractionation of the total skin secre-
tion from two R. esculenta specimens. After stimulation, the frogs 
were washed with 6 ml 0.05% acetic acid. Of the acetic acid used, 5 
ml was recovered, freeze-dried and redissolved in 3 ml 20% ethanol. 
One sixth of this solution was analyzed by HPLC. A: HPLC chro-
matogram of the total skin secretion of the control frog. The hori-
zontal bar indicates fractions with known antibacterial activity; the 
arrow indicates the esculentin peak. B: The corresponding chroma-
togram from the GC-treated frog. 
Fig. 2. Northern blot analysis of total RNA from skin of R. escu-
lenta. A cDNA encoding the esculentin precursor (Esc) was used as 
probe. Lane 1, wild frog; lanes 2 and 4, frogs treated with glucocor-
ticoid for a week; lane 3, control frog kept in a cage for a week; 
lanes 5 and 6, two frogs given a GC injection under the dorsal skin 
or intraperitoneally, respectively. A probe encoding human actin 
was used as control. This experiment was repeated three times. 
When frogs were given an electrical stimulation to discharge 
the peptides stored in the glands, no bacteria could be recov-
ered from the mouth 30 min later. After a stimulation, the 
skin secretion visibly enters the mouth of the animal either 
through the mouth itself or through the orifices located close 
to the eyes. Frogs receiving a single dose of glucocorticoid 
cream on the skin surface showed after 48 h an increase in 
mouth bacteria to around 4000 cfu/5 μΐ saliva. Three days 
after the electrical stimulation, the amount of bacteria was 
restored to 40 in the untreated frog, and decreased to 400 in 
the GC-treated animal, thus approaching the normal values. 
In the next set of experiments, two different frog specimens 
were electrically stimulated and carefully washed. One of the 
frogs received for a week a daily treatment with the GC 
cream, the other was an untreated control. After 7 days, the 
skin secretions of both frogs were collected and their antibac-
terial activity against Escherichia coli D21 was recorded with 
the inhibition zone assay [17]. The secretion of the GC-treated 
frog showed only 7% of the activity of the untreated control. 
Moreover, the secretions of the two frogs were analyzed by 
HPLC. The secretion of the control frog (Fig. 1A) gave a 
Chromatographie pattern typical for the occurrence of the 
various families of antibacterial peptides of К esculenta [9], 
whereas the secretion of the GC-treated frog gave no signifi-
cant peptide peaks (Fig. IB). Thus, the GC treatment resulted 
in the disappearance of all known antibacterial peptides in the 
skin secretion. 
To date, no gene structures are available that encode anti-
bacterial peptides from Rana species. However, a Northern 
blot analysis of total RNA from skin of R. esculenta, using 
as probe a cDNA encoding the precursor of esculentin [9], 
shows clearly that GC treatment of the frog skin blocked 
the transcription of the esculentin gene (Fig. 2). Since the 
preproregions of the precursors of all antimicrobial peptides 
present in the skin secretion of R. esculenta are very similar 
[9], and since our hybridization conditions were not highly 
stringent, we believe that no antimicrobial peptide genes are 
transcribed, as supported by the results shown in Fig. 1. Fig. 2 
also shows total RNA from two frogs injected with a soluble 
glucocorticoid, one in the dorsal sac under the skin, the other 
intraperitoneally. In both cases, the esculentin probe gave 
weak signals. The fact that the signals did not completely 
disappear may be due either to the lack of systemic action 
or to a too low dose of the glucocorticoid. 
In order to establish whether in R esculenta the glucocorti-
coid treatment was associated with an increase in ΙκΒα levels, 
a cytoplasmic extract of proteins from R esculenta skin was 
analyzed by immunoblotting with ΙκΒα antibodies. Fig. 3 
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antibacterial peptides, LL-37 [26] and a ß-defensin [27], it 
seems possible that GC treatment of human skin (or other 
epithelia) could also cause some undesirable infection. Thus, 
the results here presented may have clinical relevance in sev-
eral situations. 
Fig. 3. Immunoblot analysis of total cytoplasmic proteins from R. 
esculenta skin with polyclonal rabbit antibodies against a synthetic 
peptide corresponding to residues 26-39 from the N-terminus of hu-
man ΙκΒα (New England Biolabs Inc.). Proteins were separated by 
12% SDS polyacrylamide gels and then electroblotted on nitrocellu-
lose. Immunostaining of the peroxidase-linked antibodies was ac-
cording to the manufacturer's instructions with minor modifications. 
Markers, biotinylated proteins with the Mr given as kDa; lane 1, 
control frog; lane 2, frog treated with glucocorticoid cream for a 
week. This experiment was repeated four times (attempting to mini-
mize the background). 
shows significant levels of ΙκΒα in the skin of GC-treated 
frogs, while the amount in the control is below the level of 
detection. Electrophoretic mobility of ΙκΒα derivatives can 
vary a great deal depending on the number of ankyrin repeats, 
the extension of the N-terminal portion and the degree of 
phosphorylation (factors not yet known). However, the size 
of around 40 kDa (estimated from the markers in Fig. 3) is in 
good agreement with the size of human ΙκΒα. Migration as a 
doublet was observed also for human ΙκΒα [18]. Moreover, 
microscopic analysis of skin glands of GC-treated R. esculenta 
showed that the secretory granules, known to contain the 
stored peptides in normal glands, were lacking (M. Simmaco 
and T. Renda, unpublished results). 
4. Discussion 
There is a vast and recent literature on the transcriptional 
control of NF-κΒ in both mammals [19] and insects [20], in-
cluding the induction of ΙκΒα in cell cultures incubated with 
GC [4,5]. In insects, NF-κΒ is also involved in the control of 
both immunity and body development [21]. It was first shown 
that the expression of immune genes in Cecropia was con-
trolled by Cif, a transcription factor immunologically cross-
reacting with mammalian N F - K B [22]. Then, different genes 
for peptide antibiotics in Drosophila, Sarcophaga and Anophe-
les were found to be regulated by NF-кВЛкВ-Нке interactions 
[23-25]. However, so far no immunological effector molecules 
in live vertebrates have been shown to be under N F - K B / I K B 
control and affected by GC treatment. Here, we demonstrate 
by HPLC analysis (Fig. 1) that GC treatment of R. esculenta 
causes a complete loss of all antimicrobial peptides in the skin 
secretion, presumably by blocking the transcription of the 
genes encoding these peptides (Fig. 2). This explains the in-
crease of viable mouth bacteria initially observed in GC-
treated frogs. Moreover, immunoblotting of skin proteins 
shows that GC treatment induces significant levels of ΙκΒα, 
while this factor can hardly be detected in untreated skin (Fig. 
3). The genes for peptide antibiotics in both human and in-
sects [6-8,20,21] have binding sites for NF-κΒ, and the results 
described can be expected to apply to many different species. 
Since human skin was recently found to produce two different 
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